Patents by Inventor Danièle Gilbert

Danièle Gilbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20140086895
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of autoimmune diseases, especially rheumatoid arthritis. More particularly, the present invention relates to an a-enolase polypeptide for use in the prophylactic treatment of an autoimmune disease in a subject in need thereof.
    Type: Application
    Filed: May 10, 2012
    Publication date: March 27, 2014
    Applicants: Universite de Rouen, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Olivier Vittecoq, Céline Derambure, Thierry Lequerre, Olivier Boyer, Francois Tron, Xavier Le Loet, Daniêle Gilbert
  • Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases
    Patent number: 8216790
    Abstract: The application relates to a method of diagnosing neuropsychiatric diseases, eating disorders and/or metabolic diseases, which comprises: (i) measuring the affinity and/or the avidity of antibodies, derived from a biological sample, directed against a biological molecule involved in homeostatic regulation and/or in motivational behavior and/or in emotion; (ii) comparing the affinity value obtained with a control value.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: July 10, 2012
    Inventors: Serguei Fetissov, Pierre Dechelotte, Maria Hamze-Sinno, Danièle Gilbert
  • METHOD OF DIAGNOSING NEUROPHSYCHIATRIC DISEASES, EATING DISORDERS OR METABOLIC DISEASES
    Publication number: 20090305434
    Abstract: The application relates to a method of diagnosing neuropsychiatric diseases, eating disorders and/or metabolic diseases, which comprises: (i) measuring the affinity and/or the avidity of antibodies, derived from a biological sample, directed against a biological molecule involved in homeostatic regulation and/or in motivational behavior and/or in emotion; (ii) comparing the affinity value obtained with a control value.
    Type: Application
    Filed: October 3, 2007
    Publication date: December 10, 2009
    Inventors: Serguei Fetissov, Pierre Dechelotte, Maria Hamze-Sinno, Danièle Gilbert